National Translational Research Group — Port Jefferson Station, New York

National Translational Research Group is a clinical research site located in Port Jefferson Station, New York, United States 11776.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

National Translational Research Group has participated in 1 clinical trials.

Therapeutic areas: Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC).

Sponsors: Genentech, Inc..

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for National Translational Research Group?

National Translational Research Group has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has National Translational Research Group conducted?

National Translational Research Group has 1 clinical trials on record. Their work covers Non-Small Cell Lung Cancer (NSCLC), Small-Cell Lung Cancer (SCLC).

Is National Translational Research Group accredited by Crixeo Health?

National Translational Research Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about National Translational Research Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.